Chai Discovery
Technology
Company overview
Chai Discovery builds artificial intelligence tools for drug discovery. Its computer-aided design suite lets scientists design new medicines computationally. The platform handles molecular engineering, including antibody design against difficult targets, with atomic-level precision. The company raised $400 million in a Series C round and has worked with drug makers including Novartis, Pfizer, Eli Lilly, and argenx. Chai Discovery is an H-1B sponsor.
- Industry
- Technology
- Headquarters
- San Francisco Office, United States